News

As Seen In
Cell Therapy is “Hair Raising” in a Good Way
10 years ago Apr 14, 2015
RepliCel Targets Low-Risk, Near-Term Opportunities in Regenerative MedicineBy: Gail DuttonThe regenerative medicine company RepliCel Life...
Press Release
RepliCel Life Sciences Receives Approval to Conduct Clinical Trial for Patients with Chronic Achilles Tendinosis
10 years ago Apr 14, 2015
The University of British Columbia Clinical Research Ethics Board Clears Clinical Trial to Proceed with...
Press Release
RepliCel Life Sciences Receives TSX Venture Exchange Approval to Extend Warrant Expiry Dates
10 years ago Apr 06, 2015
VANCOUVER, BC – April 7, 2015 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Life Sciences Applies to Extend Warrant Expiry Dates
10 years ago Apr 01, 2015
VANCOUVER, BC – April 2, 2015 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Meets with Japanese Pharmaceutical and Medical Devices Agency (PMDA)
10 years ago Mar 22, 2015
As part of its Japanese partnering strategy, RepliCel seeks advice of Japanese regulators around its...
As Seen In
The Life Sciences Report: Will Stem Cell Profits Measure Up?
10 years ago Mar 18, 2015
To read the article on The Life Sciences Report, click here: It makes no sense...
As Seen In
Stockhouse: RepliCel Hits Lucrative Bio-med Trifecta with Innovative Tech
10 years ago Mar 15, 2015
To read the article on Stockhouse click here Until 2011, RepliCel Life Sciences (TSX: V.RP,...
As Seen In
The Province: Four Biotech Companies that are Helping B.C. Lead the Battle Against Aging
10 years ago Mar 13, 2015
To read the full article on The Province newspaper website click here\n\nA Vancouver-based anti-aging company...
Press Release
RepliCel Life Sciences in Japan for Key Industry Meetings
10 years ago Mar 11, 2015
Autologous cell therapy, RCS-01, to be investigated as a potential treatment for aged, UV-damaged skin...
As Seen In
Financial Post: Seeking to Cure the Incurable
10 years ago Mar 09, 2015
To read the article on the Financial Post website click here.\n\nCanada and Japan are taking...
As Seen In
Streetwise Report Interviews BioWatch News Founder Alan Leong
10 years ago Mar 03, 2015
To read the full report, click here. Biotechnology can be daunting to comprehend, but understanding...
Press Release
RepliCel Submits Clinical Trial Application for its Dermatological Clinical Trial
10 years ago Feb 22, 2015
Autologous cell therapy, RCS-01, to be investigated as a potential treatment for aged, UV-damaged skin...
As Seen In
The Total Tutor Interviews CEO David Hall on BlogTalkRadio
10 years ago Feb 19, 2015
RepliCel’s CEO David Hall is interviewed by The Total Tutor Neil Haley on blogtalkradio. Hall...
As Seen In
Houston Style Magazine Interviews RepliCel CEO
10 years ago Feb 03, 2015
 New Treatment for NFL Players and Pro Athletes Offers New HopeStory by: Jo-CarolynNew York, NY,...
As Seen In
CEO David Hall Interviewed on ESPN New York Radio
10 years ago Jan 27, 2015
To listen to the full interview, click here or view the file below. CEO &...
Events
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
10 years ago Jan 19, 2015
VANCOUVER, BC – January 20, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...
Events
RepliCel Life Sciences to Present at Biotech Showcase 2015
10 years ago Jan 06, 2015
Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapiesVANCOUVER, BC...
Press Release
Newly Released Peer-Reviewed Publication Further Validates RepliCels Use of Dermal Sheath Cup Cells to Treat Pattern Baldness
10 years ago Dec 21, 2014
VANCOUVER, BC – December 22, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),...
As Seen In
VP Lee Buckler Podcast Interview by Midas Letter
10 years ago Dec 18, 2014
Written By: James West Listen to the full interview here. RepliCel’s VP Lee Buckler explains...
As Seen In
Chronic Achilles Tendinosis Video Launched
10 years ago Dec 01, 2014
Using Your Own Cells to Heal Tendon InjuriesRepliCel is developing an autologous cell-based product for...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.